SCHEMBL16484366

SCHEMBL16484366

c1cnc2ccc(-n3c4ccccc4c4ccccc43)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.55
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 4/20 0.55
GAA P10253 2/20 0.55
NCOA3 Q9Y6Q9 1/20 0.51
POLB P06746 4/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 1/20 0.49
CHRNA7 P36544 1/20 0.48
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
MAPK10 P53779 1/20 0.47
TP53 P04637 2/20 0.47
PSMD14 O00487 1/20 0.47
MMP2 P08253 1/20 0.47
TSHR P16473 2/20 0.46
HSD17B10 Q99714 2/20 0.46
ATM Q13315 2/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17989061 0.87 ALDH1A1 (0.47) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL10110998 0.86 ALDH1A1 (0.52) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL12613896 0.84 NPC1 (0.51) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL17989928 0.84 ALDH1A1 (0.47) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL16452122 0.84 ALDH1A1 (0.44) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL17989909 0.83 KDM4E (0.44) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL20062364 0.83 ALDH1A1 (0.39) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL20062360 0.83 ALDH1A1 (0.39) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL20062356 0.83 ALDH1A1 (0.39) MAPTALDH1A1KDM4EGAANCOA3
SCHEMBL20062368 0.83 ALDH1A1 (0.39) MAPTALDH1A1KDM4EGAANCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190305228-A1 ORGANIC LIGHTEMITTING COMPOUND HAVING PHOSPHORESCENT CHARACTERISTIC AT ROOM TEMPERATURE, AND PHOSPHORESCENT ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANIC LIGHTEMITTING COMPOUND RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVER SITY (KR) 2019-10-03 US disclosed
US-9935273-B2 Fluoranthene derivative, light-emitting device material containing same, and light-emitting device TORAY INDUSTRIES, INC. (JP) 2018-04-03 US disclosed
US-9935273-B2 Fluoranthene derivative, light-emitting device material containing same, and light-emitting device TORAY INDUSTRIES, INC. (JP) 2018-04-03 US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 US disclosed
EP-2907803-A1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT Toray Industries, Inc. (JP) 2015-08-19 EP disclosed
WO-2014057874-A1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT 東レ株式会社 (JP) 2014-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE FMNL1, AFF2, LEF1 MAPT 937/4885ALDH1A1 1031/4885KDM4E 502/4885
US-20190305228-A1 ORGANIC LIGHTEMITTING COMPOUND HAVING PHOSPHORESCENT CHARACTERISTIC AT ROOM TEMPERATURE, AND PHOSPHORESCENT ORGANIC LIGHT EMITTING DEVICE INCLUDING THE ORGANIC LIGHTEMITTING COMPOUND MAP1LC3C, MAP1LC3A, MAP1LC3B MAPT 494/4885ALDH1A1 250/4885KDM4E 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.